Related Experiment Video
Updated: Feb 1, 2026

Single Cell Micro-aspiration as an Alternative Strategy to Fluorescence-activated Cell Sorting for Giant Virus Mixture Separation
Published on: October 27, 2019
Defining giant mandibular ameloblastomas - Is a separate clinical sub-entity warranted?
Aditya V Kanoi1, Tibar Banerjee1, Narayanamurthy Sundaramurthy1
1Department of Plastic and Reconstructive Surgery, Institute of Postgraduate Medical Education and Research, Kolkata, West Bengal, India.
This study defines giant mandibular ameloblastoma (GMA) using objective criteria to aid in diagnosis and treatment. The proposed criteria help manage these large jaw tumors more effectively.
Area of Science:
- Oral and Maxillofacial Surgery
- Oncology
- Reconstructive Surgery
Background:
- The term giant mandibular ameloblastoma (GMA) lacks clear definition in medical literature.
- Existing criteria for GMAs are arbitrary and do not aid clinical decision-making or management.
Purpose of the Study:
- To establish objective, clinically relevant criteria for identifying giant mandibular ameloblastomas (GMAs).
- To improve the management and decision-making process for GMAs.
Main Methods:
- Retrospective analysis of 16 ameloblastoma patients from August 2012 to September 2016.
- Application of proposed criteria to identify 11 cases of GMAs.
Main Results:
- Segmental mandibular defects after resection measured 7-11.5 cm (mean 9.3 cm).
- No recurrence observed in 11 identified GMAs during a mean follow-up of 10.7 months.
Conclusions:
- Objective criteria for GMAs reduce ambiguity and simplify treatment planning.
- Inclusion criteria for GMAs: segmental defect >6 cm with 1 cm margin, involving central mandible.
Related Concept Videos
Defining Psychology
Defining Social Psychology
Piecewise-Defined Functions
Rules for Defining Functions
Polymers: Defining Molecular Weight
The number average molecular weight (Mn) is the summation of the number...
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...

